The Patent Finder

Platinum Compounds, Compositions, and Uses Thereof (2017)

Xlink Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,322,137Platinum Compounds, Compositions, and Uses Thereof
In force
 · High confidence
UsedRemaining
Xlink Therapeutics, Inc.In forceHigh confidence
US 9,403,858Platinum Compounds, Compositions, and Uses Thereof
Lapsed Aug 2, 2024 on the fee record
High confidence
Xlink Therapeutics, Inc.Lapsed Aug 2, 2024 on the fee recordHigh confidence
US 9,937,187Platinum Compounds, Compositions, and Uses Thereof
Lapsed Apr 10, 2026 on the fee record
High confidence
Xlink Therapeutics, Inc.Lapsed Apr 10, 2026 on the fee recordHigh confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Xlink Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited